← 產業報告目錄

Artificial Intelligence (AI) in Healthcare Market by Function (Imaging, Robotics, AI Scribe, Telehealth, CDS, Precision Medicine, Radiation, RCM, Cybersecurity), Tools (ML, NLP, Computer Vision), End User (Hospital, ASC, Payer) - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2026-06-23頁數 798報告編號 HIT9226

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global artificial intelligence (AI) in healthcare market is projected to reach USD 194.79 billion by 2031 from USD 36.67 billion in 2026, at a CAGR of 39.7% during the forecast period. The AI in healthcare market is growing rapidly as hospitals and health systems increasingly deploy AI solutions to improve clinical efficiency, reduce physician burnout, and enhance patient outcomes. For example, in 2025, the Cleveland Clinic rolled out Ambience Healthcare’s AI documentation platform across its US outpatient network after evaluating the technology across more than 80 specialties. The solution was adopted by over 4,000 clinicians within 15 weeks of deployment, enabling documentation for more than one million patient encounters. Additionally, in January 2026, Aultman Health System deployed Nabla’s ambient AI solution across hundreds of clinicians through integration with Oracle Cerner, while AtlantiCare reported a 50% reduction in documentation time after implementing Oracle Health’s Clinical AI Agent. As real-world adoption continues to expand across hospitals, clinics, and health systems, AI is expected to play an increasingly critical role in shaping the future of healthcare delivery worldwide. By deployment, the cloud-based models segment is expected to register the highest growth during the forecast period. The AI in healthcare market is categorized into three deployment models: on-premises, cloud-based, and hybrid. The cloud-based models segment holds the largest share due to their scalability, cost-effectiveness, and accessibility. Cloud-based models facilitate real-time data processing and collaboration. They enable seamless integration, secure data storage, and rapid deployment, making them particularly well-suited for healthcare providers and payers. They provide faster, more reliable care while maintaining high-quality standards. Cloud-based AI solutions are becoming increasingly popular due to their cost-effectiveness, scalability, and support for remote access. These solutions enable seamless integration and real-time analytics. The growing adoption of telehealth and advancements in healthcare IT infrastructure further drive the demand for cloud-based models. By end user, the hospitals & clinics segment dominated the artificial intelligence (AI) in healthcare market for healthcare providers in 2025. By end user, the artificial intelligence (AI) in healthcare market for healthcare providers is segmented into hospitals & clinics, ambulatory surgical centers, home healthcare agencies & assisted living facilities, diagnostic & imaging centers, pharmacies, and other healthcare providers. The hospitals & clinics segment accounted for the largest share of the artificial intelligence (AI) in healthcare market for healthcare providers. This is attributed to the increasing demand for personalized medicines, precise diagnostics & surgical planning, growth in minimally invasive procedures, and the requirement for interoperability with existing systems. AI-based healthcare solutions enhance diagnostic accuracy, streamline operations, and personalize care in hospitals and clinics. They automate administrative tasks, predict patient outcomes, and enable faster decision-making with real-time data analysis. AI also supports remote monitoring, optimizes resources, and reduces costs by minimizing unnecessary treatments. The Asia Pacific is expected to register the highest growth during the forecast period. The artificial intelligence (AI) in healthcare market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is the fastest growing in the AI in healthcare market, driven by rapid healthcare digitalization, increasing investments in artificial intelligence, expanding adoption of electronic health records (EHRs), and strong government support for digital health initiatives. Countries such as China, India, Singapore, Japan, and South Korea are actively integrating AI into diagnostics, medical imaging, clinical decision support, and hospital workflow management. For instance, in February 2026, India launched its Strategy for AI in Healthcare (SAHI), establishing a national framework for the responsible and large-scale adoption of AI across the healthcare ecosystem. Healthcare providers across the region are also expanding AI adoption. In Singapore, the Ministry of Health is scaling generative AI for clinical documentation and AI-powered imaging solutions across the public healthcare system, while hospitals such as Ng Teng Fong General Hospital are using AI-enabled tools to improve patient management and care delivery. The breakdown of primary participants is as mentioned below: • By Company Type: Tier 1 (32%), Tier 2 (44%), and Tier 3 (24%) • By Designation: Directors (30%), Managers (34%), and Others (36%) • By Region: North America (40%), Europe (28%), Asia Pacific (20%), Latin America (7%), and the Middle East & Africa (5%) Key Players The prominent players operating in the artificial intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Veradigm LLC (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), Amazon Web Services, Inc. (US), SOPHiA GENETICS (US), Riverian Technologies (US), Terarecon (ConcertAI) (US), Solventum Corporation (US), Tempus (US), Viz.ai (US). These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, mergers, and acquisitions to strengthen their market presence in the artificial intelligence (AI) in healthcare market. Research Coverage The report analyzes the artificial intelligence (AI) in healthcare market and estimates the market size and future growth potential of various market segments by offering, function, application, deployment model, tool, end user, and region. The report also analyses factors (such as drivers, restrains, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges for market stakeholders. The report also examines micromarkets in terms of their growth trends, prospects, and contributions to the total artificial intelligence (AI) in healthcare market. The report forecasts revenue for the market segments across five major regions. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies. Reasons to Buy the Report This report will help established firms, as well as new entrants/smaller firms, gauge the market pulse, which, in turn, will help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market positions. This report provides insights on: • Analysis of key drivers (rapid proliferation of AI in healthcare sector and growing need for improved healthcare services), restraints (shortage of skilled AI professionals handling AI-powered solutions and lack of standardized frameworks for AI and ML technologies), opportunities (strategic partnerships and collaborations among healthcare companies and AI technology providers and increase in focus on developing human-aware AI systems), challenges (concerns regarding data privacy and lack of interoperability) are factors contributing the growth of the artificial intelligence (AI) in healthcare market. • Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and software launches in the artificial intelligence (AI) in healthcare market. • Market Development: Comprehensive information on the lucrative emerging markets, offering, function, application, deployment, tool, end user, and region • Market Diversification: Exhaustive information about software portfolios, growing geographies, recent developments, and investments in the artificial intelligence (AI) in healthcare market. • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global artificial intelligence (AI) in healthcare market, such as Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), and Epic Systems Corporation (US).
目錄 Table of Contents
1 INTRODUCTION 66 1.1 STUDY OBJECTIVES 66 1.2 MARKET DEFINITION 66 1.3 MARKET SCOPE 67 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 67 1.3.2 INCLUSIONS AND EXCLUSIONS 68 1.3.3 YEARS CONSIDERED 71 1.4 CURRENCY CONSIDERED 72 1.5 STAKEHOLDERS 72 2 EXECUTIVE SUMMARY 73 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 73 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 75 2.3 DISRUPTIVE TRENDS IN AI IN HEALTHCARE MARKET 76 2.4 HIGH-GROWTH SEGMENTS 77 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 78 3 PREMIUM INSIGHTS 79 3.1 AI IN HEALTHCARE MARKET OVERVIEW 79 3.2 AI IN HEALTHCARE MARKET, BY APPLICATION AND REGION 80 3.3 AI IN HEALTHCARE MARKET: GEOGRAPHIC SNAPSHOT 80 4 MARKET OVERVIEW 81 4.1 INTRODUCTION 81 4.2 MARKET DYNAMICS 81 4.2.1 DRIVERS 82 4.2.1.1 Increasing need for early detection and diagnosis of diseases 82 4.2.1.2 Exponential growth in data volume and complexity due to surging adoption of digital technologies 83 4.2.1.3 Significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases 84 4.2.1.4 Rapid proliferation of AI in healthcare sector 84 4.2.1.5 Growing inclination toward precision medicine and personalized care 85 4.2.2 RESTRAINTS 86 4.2.2.1 Reluctance among medical practitioners to adopt AI-based technologies 86 4.2.2.2 Shortage of skilled AI professionals handling AI-powered solutions 86 4.2.2.3 Lack of standardized frameworks for AI and ML technologies 87   4.2.3 OPPORTUNITIES 87 4.2.3.1 Rising demand for AI-driven clinical decision support systems 87 4.2.3.2 Increasing focus on developing human-aware AI systems 88 4.2.3.3 Strategic partnerships and collaborations among healthcare companies and AI technology providers 89 4.2.3.4 Rising adoption of AI-enabled medical imaging and diagnostics 90 4.2.4 CHALLENGES 91 4.2.4.1 Inaccurate predictions due to scarcity of high-quality healthcare data 91 4.2.4.2 Concerns regarding data privacy 91 4.2.4.3 Lack of interoperability between AI solutions offered by different vendors 92 4.3 UNMET NEEDS AND WHITE SPACES 92 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 93 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 93 5 INDUSTRY TRENDS 94 5.1 PORTER’S FIVE FORCES ANALYSIS 94 5.1.1 THREAT OF NEW ENTRANTS 95 5.1.2 THREAT OF SUBSTITUTES 96 5.1.3 BARGAINING POWER OF SUPPLIERS 96 5.1.4 BARGAINING POWER OF BUYERS 96 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 96 5.2 MACROECONOMIC OUTLOOK 97 5.2.1 INTRODUCTION 97 5.2.2 GDP TRENDS AND FORECAST 97 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 97 5.3 VALUE CHAIN ANALYSIS 97 5.4 ECOSYSTEM ANALYSIS 99 5.5 PRICING ANALYSIS 100 5.5.1 INDICATIVE PRICING FOR AI IN HEALTHCARE, BY APPLICATION (2025) 100 5.5.2 INDICATIVE PRICING FOR AI IN HEALTHCARE MARKET, BY REGION (2025) 101 5.6 KEY CONFERENCES AND EVENTS, 2026–2027 102 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 102 5.8 INVESTMENT AND FUNDING SCENARIO 103 5.9 CASE STUDY ANALYSIS 104 5.9.1 ACCELERATING LUNG CANCER DIAGNOSIS THROUGH AI ACROSS NHS HOSPITALS 104 5.9.2 STRENGTHENING PATIENT TRUST THROUGH DIGITAL PATIENT ENGAGEMENT SOLUTIONS 104 5.9.3 OPTIMIZING PATIENT ENGAGEMENT AND COMMUNICATION WITH TRUBRIDGE PATIENT CONNECT 105   5.10 IMPACT OF US TARIFF – OVERVIEW 105 5.10.1 INTRODUCTION 105 5.10.2 KEY TARIFF RATES 106 5.10.3 PRICE IMPACT ANALYSIS 107 5.10.4 IMPACT ON COUNTRIES/REGIONS 107 5.10.4.1 US 107 5.10.4.2 Europe 108 5.10.4.3 Asia Pacific 109 5.10.5 IMPACT ON END USERS 109 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 111 6.1 KEY EMERGING TECHNOLOGIES 111 6.1.1 MACHINE LEARNING AND DEEP LEARNING 111 6.1.2 NATURAL LANGUAGE PROCESSING 111 6.1.3 COMPUTER VISION 111 6.2 COMPLEMENTARY TECHNOLOGIES 112 6.2.1 CLOUD COMPUTING 112 6.2.2 DIGITAL TWINS 112 6.2.3 ROBOTIC PROCESS AUTOMATION 112 6.3 ADJACENT TECHNOLOGIES 112 6.3.1 BLOCKCHAIN 112 6.3.2 AUGMENTED REALITY AND VIRTUAL REALITY 113 6.3.3 INTERNET OF THINGS 113 6.4 PATENT ANALYSIS 113 6.4.1 PATENT PUBLICATION TRENDS FOR AI IN HEALTHCARE LANDSCAPE 113 6.4.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 114 6.5 FUTURE APPLICATIONS 116 6.5.1 AI-DRIVEN PRECISION MEDICINE 116 6.5.2 REAL-TIME CLINICAL DECISION SUPPORT WITH GENERATIVE AI 117 6.5.3 DISEASE PREDICTION AND EARLY INTERVENTION THROUGH PREDICTIVE ANALYTICS 117 6.5.4 AI-POWERED VIRTUAL HEALTH ASSISTANTS AND DIGITAL CARE NAVIGATION 117 6.5.5 ADVANCING AUTONOMOUS AI AGENTS FOR HEALTHCARE WORKFLOW AUTOMATION 117 7 REGULATORY LANDSCAPE 118 7.1 REGIONAL REGULATIONS AND COMPLIANCE 118 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 118 7.1.2 REGULATORY FRAMEWORK 120   8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 124 8.1 INTRODUCTION 124 8.2 DECISION-MAKING PROCESS 124 8.3 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 124 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 125 8.3.2 BUYING CRITERIA 125 8.4 ADOPTION BARRIERS AND INTERNAL CHALLENGES 126 8.5 UNMET NEEDS OF VARIOUS END USERS 127 8.5.1 UNMET NEEDS 127 8.5.2 END-USER EXPECTATIONS 128 8.6 MARKET PROFITABILITY 129 8.7 IMPACT ON COUNTRIES/REGIONS 130 8.7.1 US 130 8.7.2 EUROPE 131 8.7.3 ASIA PACIFIC 131 8.8 IMPACT ON END USERS 132 9 AI IN HEALTHCARE MARKET, BY FUNCTION 133 9.1 INTRODUCTION 134 9.2 DIAGNOSIS & EARLY DETECTION 134 9.2.1 PRE-SCREENING 135 9.2.1.1 Early detection, better outcomes, and cost-effective care associated with pre-screening to boost market 135 9.2.2 IVD 136 9.2.2.1 IVD market, by technology 137 9.2.2.1.1 Immunoassays 137 9.2.2.1.1.1 Potential to enhance biomarker detection and laboratory automation to accelerate demand 137 9.2.2.1.2 Clinical chemistry 138 9.2.2.1.2.1 Ability to improve laboratory efficiency and diagnostic accuracy to spur adoption 138 9.2.2.1.3 Molecular diagnostics 139 9.2.2.1.3.1 Pressing need to identify viral and bacterial pathogens in infectious diseases to facilitate adoption 139 9.2.2.2 IVD market, by application 140 9.2.2.2.1 Image analysis & interpretation 141 9.2.2.2.1.1 Rising focus of pathologists on analyzing tissue samples for detecting abnormalities at faster rate to fuel segmental growth 141 9.2.2.2.2 Biomarker discovery & analysis 142 9.2.2.2.2.1 Elevating adoption of precision medicine to create growth opportunities 142 9.2.2.2.3 Other IVD applications 142   9.2.3 DIAGNOSTIC IMAGING 143 9.2.3.1 Diagnostic imaging market, by application 144 9.2.3.1.1 Disease interpretation & report analysis 144 9.2.3.1.1.1 Proficiency in identifying disease-specific patterns and correlating findings across multiple data sources to fuel adoption 144 9.2.3.1.2 Image captioning & annotation 145 9.2.3.1.2.1 Increasing use of machine learning for automated image captioning to foster market growth 145 9.2.3.1.3 Image reconstruction 146 9.2.3.1.3.1 Greater emphasis of healthcare facilities on optimizing imaging workflows and increasing scanner throughput to augment adoption 146 9.2.3.1.4 Other diagnostic imaging applications 147 9.2.3.2 Diagnostic imaging market, by modality 148 9.2.3.2.1 Magnetic resonance imaging 148 9.2.3.2.1.1 Escalating adoption of AI across MRI workflows to enhance diagnostic confidence and improve scanner utilization to augment market growth 148 9.2.3.2.2 Computed tomography 149 9.2.3.2.2.1 Urgent need for efficient diagnosis to provide the right treatments to drive market 149 9.2.3.2.3 X-ray imaging 150 9.2.3.2.3.1 Development of innovative AI-based X-ray imaging solutions to drive market 150 9.2.3.2.4 Ultrasound 151 9.2.3.2.4.1 Increasing investments in developing AI-assisted ultrasound imaging auto-assessment tools to expedite market growth 151 9.2.3.2.5 Nuclear imaging 152 9.2.3.2.5.1 Integration of AI algorithms for quick detection and monitoring of abnormalities to facilitate market growth 152 9.2.3.2.6 Other diagnostic imaging modalities 153 9.2.4 RISK ASSESSMENT & PATIENT STRATIFICATION 154 9.2.4.1 Critical need to identify high-risk patients and predict their disease progression risks to boost demand 154 9.2.5 DRUG ALLERGY ALERTING 155 9.2.5.1 Significant focus on improving accuracy and speed of identifying allergic reactions to contribute to market growth 155 9.2.6 OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS 155 9.3 TREATMENT PLANNING & PERSONALIZATION 156 9.3.1 PERSONALIZED TREATMENT PLANNING 157 9.3.1.1 Precision medicine & genomic analysis 158 9.3.1.1.1 Adoption of AI-based software for personalized treatment decisions and improved outcomes to propel market 158 9.3.1.2 Predictive models for treatment response 159 9.3.1.2.1 Ability to personalize therapies, improve outcomes, and minimize adverse effects to fuel growth 159 9.3.1.3 Treatment recommendation systems 160 9.3.1.3.1 Competency in offering personalized, evidence-based treatment options to spike demand 160 9.3.2 PHARMACOLOGICAL THERAPY 161 9.3.2.1 Drug response prediction 162 9.3.2.1.1 Increasing use of AI-powered drug response prediction in oncology and chronic disease management to drive market 162 9.3.2.2 Dosing & administration 163 9.3.2.2.1 Capability of AI-based dosing models to adjust doses in real-time based on individual patient responses to spur demand 163 9.3.2.3 Other pharmacological therapy functions 164 9.3.3 SURGICAL THERAPY 164 9.3.3.1 Preoperative imaging & 3D modeling 165 9.3.3.1.1 Widening use of AI-driven 3D modeling in orthopedic, cardiovascular, neurological surgeries to fuel market growth 165 9.3.3.2 Intraoperative guidance & robotics 166 9.3.3.2.1 Inclination toward minimally invasive surgeries and faster patient recovery to boost implementation 166 9.3.3.3 Postoperative analysis & recovery 167 9.3.3.3.1 Ability to predict recovery patterns, identify risks, and provide personalized rehabilitation plans to boost demand 167 9.3.4 RADIATION THERAPY 168 9.3.4.1 Motion synchronization & auto contouring 169 9.3.4.1.1 Need for precise delivery of radiation and minimum exposure to surrounding healthy tissues to reinforce segmental growth 169 9.3.4.2 Real-time adaptive treatment delivery 170 9.3.4.2.1 Growing focus on consistent treatment accuracy and clinical outcome optimization to strengthen demand 170 9.3.4.3 Response assessment & quality assurance 171 9.3.4.3.1 Ability of AI solutions to analyze medical images, treatment plans, and dosimetric data to accelerate demand 171 9.3.4.4 Other radiation therapy functions 172 9.3.5 BEHAVIORAL THERAPY & PSYCHOTHERAPY 173 9.3.5.1 Virtual counseling & chatbots 174 9.3.5.1.1 Potential to improve patient communication, engagement, and service efficiency to expand implementation 174 9.3.5.2 Progress monitoring & feedback 175 9.3.5.2.1 Increasing use of smart wearables and mobile health apps to drive market 175 9.3.5.3 Follow-up & long-term support 175 9.3.5.3.1 Widespread adoption of telemedicine platforms to drive market expansion 175   9.3.6 IMMUNOTHERAPY 176 9.3.6.1 Real-time patient data monitoring 177 9.3.6.1.1 High demand for proactive healthcare management to foster segmental growth 177 9.3.6.2 Response & side-effect prediction 178 9.3.6.2.1 Need for earlier detection of treatment-related risks across drugs and vaccines to support segmental growth 178 9.3.6.3 Relapse prediction & long-term management 179 9.3.6.3.1 Necessity for continuous patient monitoring and risk stratification to fuel demand 179 9.3.7 OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS 180 9.4 PATIENT ENGAGEMENT & REMOTE MONITORING 181 9.4.1 SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE 182 9.4.1.1 Constant requirement for symptom management in chronic diseases to accelerate adoption of AI-powered apps 182 9.4.2 TELEHEALTH & REMOTE PATIENT MONITORING 183 9.4.2.1 Increasing adoption of mobile health apps and wearable devices to augment segmental growth 183 9.4.3 HEALTHCARE ASSISTANCE ROBOTS 184 9.4.3.1 Competency in improving quality of care and reducing burden on healthcare workers to promote adoption 184 9.4.4 MEDICATION REMINDERS 185 9.4.4.1 Capability to deliver medication guidance, personalized health coaching, and care coordination to foster demand 185 9.4.5 PATIENT EDUCATION & EMPOWERMENT 186 9.4.5.1 Need to improve treatment adherence and enhance self-management to drive market 186 9.4.6 OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS 187 9.5 POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE 188 9.5.1 RECURRENCE MONITORING 189 9.5.1.1 Advancing post-treatment care through intelligent recurrence monitoring to support market growth 189 9.5.2 LONG-TERM OUTCOME PREDICTION 189 9.5.2.1 Greater emphasis on predicting disease recurrence and survival chances to improve uptake of AI-powered medical devices 189 9.5.3 MENTAL HEALTH & SUPPORT SYSTEMS 190 9.5.3.1 Rising focus on emotional well-being of patients with critical illness to support segmental growth 190 9.6 PHARMACY MANAGEMENT 191 9.6.1 EPRESCRIBING 192 9.6.1.1 Urgent need to replace paper-based prescription to electronic platform to expedite adoption of ePrescribing solutions 192 9.6.2 MEDICATION MANAGEMENT 193 9.6.2.1 Innovative medication management programs between healthcare professionals and pharmacists to encourage segmental growth 193   9.6.3 PHARMACY AUDIT & ANALYSIS 194 9.6.3.1 Demand for operational excellence and improved patient care outcomes across pharmacies to create growth opportunities 194 9.6.4 OTHER PHARMACY MANAGEMENT FUNCTIONS 195 9.7 DATA MANAGEMENT & ANALYTICS 196 9.7.1 RISING FOCUS OF HEALTHCARE ORGANIZATIONS ON DEVELOPING PERSONALIZED TREATMENT PLANS TO SUPPORT SEGMENTAL GROWTH 196 9.8 AI SCRIBE 196 9.8.1 GROWING NEED TO IMPROVE CLINICIAN PRODUCTIVITY AND REDUCE DOCUMENTATION TIME TO STRENGTHEN AI SCRIBE DEPLOYMENT 196 9.9 CLINICAL DECISION SUPPORT SYSTEMS 197 9.9.1 INCREASING NEED FOR EVIDENCE-BASED CLINICAL DECISION-MAKING TO SPIKE ADOPTION 197 9.10 ADMINISTRATIVE 198 9.10.1 PATIENT REGISTRATION & SCHEDULING 200 9.10.1.1 Rising adoption of self-service patient registration solutions to contribute to segmental growth 200 9.10.2 PATIENT ELIGIBILITY & AUTHORIZATION 201 9.10.2.1 Growing demand for faster prior authorization workflows to facilitate market growth 201 9.10.3 REVENUE CYCLE MANAGEMENT 201 9.10.3.1 Significant need to reduce claim denials and reimbursement delays to reinforce demand 201 9.10.4 WORKFORCE MANAGEMENT 202 9.10.4.1 Growing need to optimize healthcare workforce utilization to create lucrative opportunities 202 9.10.5 SUPPLY CHAIN & INVENTORY MANAGEMENT 203 9.10.5.1 Strong focus on reducing inventory costs and waste to bolster market growth 203 9.10.6 COMPLIANCE & DOCUMENTATION 204 9.10.6.1 Increasing regulatory compliance requirements in healthcare to escalate demand for AI-based compliance & documentation 204 9.10.7 HEALTHCARE WORKFLOW MANAGEMENT 205 9.10.7.1 Surging need for end-to-end workflow automation to foster segmental growth 205 9.10.8 ASSET MANAGEMENT 206 9.10.8.1 Pressing need to improve equipment availability and reduce downtime to heighten demand for AI-based asset management 206 9.10.9 CUSTOMER RELATIONSHIP MANAGEMENT 207 9.10.9.1 Growing focus on personalized patient engagement to boost segmental growth 207 9.10.10 FRAUD DETECTION & RISK MANAGEMENT 208 9.10.10.1 Rising financial losses to drive investment in AI-based proactive risk management solutions 208   9.10.11 CYBERSECURITY 209 9.10.11.1 Critical requirement to protect sensitive patient data to propel demand for AI-powered threat detection solutions 209 9.10.12 OTHER ADMINISTRATIVE FUNCTIONS 210 10 AI IN HEALTHCARE MARKET, BY OFFERING 211 10.1 INTRODUCTION 212 10.2 INTEGRATED SOLUTIONS 212 10.2.1 ESCALATING DEPLOYMENT OF ENTERPRISE-WIDE AI PLATFORMS TO CONTRIBUTE TO SEGMENTAL GROWTH 212 10.3 NICHE/POINT SOLUTIONS 213 10.3.1 GROWING ADOPTION OF SPECIALIZED AI APPLICATIONS FOR TARGETED CLINICAL AND ADMINISTRATIVE TASKS TO DRIVE MARKET 213 10.4 AI TECHNOLOGIES 214 10.4.1 HARNESSING AI FOR IMPROVED PATIENT OUTCOMES AND OPERATIONAL EFFICIENCY TO SUPPORT MARKET GROWTH 214 10.5 SERVICES 215 10.5.1 INCREASING FOCUS ON SEAMLESS AI DEPLOYMENT AND ONGOING SUPPORT TO FACILITATE SEGMENTAL GROWTH 215 11 AI IN HEALTHCARE MARKET, BY APPLICATION 217 11.1 INTRODUCTION 218 11.2 CLINICAL APPLICATIONS 218 11.2.1 NECESSITY TO ENHANCE PATIENT MONITORING AND CLINICAL DECISION-MAKING ABILITY TO SPUR DEMAND 218 11.3 NON-CLINICAL APPLICATIONS 220 11.3.1 REQUIREMENT TO ENHANCE OPERATIONAL EFFICIENCY, REDUCE ADMINISTRATIVE BURDEN, AND ENSURE BETTER RESOURCE ALLOCATION TO FOSTER MARKET GROWTH 220 12 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL 222 12.1 INTRODUCTION 223 12.2 ON-PREMISES MODEL 223 12.2.1 CRITICALITY OF DATA PRIVACY AND SECURITY TO SUPPORT DEPLOYMENT OF ON-PREMISES HEALTHCARE INFRASTRUCTURE 223 12.3 CLOUD-BASED MODEL 224 12.3.1 RAPID SCALABILITY AND SECURE DATA HANDLING AND INTEGRATION ATTRIBUTES TO ELEVATE DEMAND FOR CLOUD-BASED AI SOLUTIONS IN HEALTHCARE 224 12.4 HYBRID MODEL 225 12.4.1 FOCUS OF HEALTHCARE ORGANIZATIONS ON PROTECTING DATA WITHOUT SACRIFICING SCALABILITY TO DRIVE SEGMENTAL GROWTH 225   13 AI IN HEALTHCARE MARKET, BY TOOL 227 13.1 INTRODUCTION 228 13.2 MACHINE LEARNING 228 13.2.1 DEEP LEARNING 230 13.2.1.1 Convolutional neural networks 231 13.2.1.1.1 Ability to analyze X-rays, CT scans, and MRIs with high precision to elevate adoption 231 13.2.1.2 Recurrent neural networks 232 13.2.1.2.1 Competency in analyzing sequential data to predict disease progression and treatment efficacy to boost deployment 232 13.2.1.3 Generative adversarial networks 233 13.2.1.3.1 Capability to generate synthetic data to train AI models and address data scarcity and privacy issues to propel demand 233 13.2.1.4 Graph neural networks 234 13.2.1.4.1 Ability to recommend personalized treatment to stimulate adoption 234 13.2.1.5 Other deep learning tools 235 13.2.2 SUPERVISED LEARNING 236 13.2.2.1 Growing importance of evidence-based decision-making in predictive and diagnostic tasks to spur demand 236 13.2.3 REINFORCEMENT LEARNING 237 13.2.3.1 Significance of precision medicine, value-based care, and intelligent clinical decision support to accelerate demand 237 13.2.4 UNSUPERVISED LEARNING 238 13.2.4.1 Increasing need to uncover hidden insights from unstructured healthcare data to boost adoption 238 13.2.5 OTHER MACHINE LEARNING TOOLS 238 13.3 NATURAL LANGUAGE PROCESSING 239 13.3.1 SENTIMENT ANALYSIS 241 13.3.1.1 Increasing adoption of AI for patient feedback analysis to contribute to market growth 241 13.3.2 PATTERN & IMAGE RECOGNITION 241 13.3.2.1 Growing utilization of AI for early disease detection and personalized treatment planning to facilitate market expansion 241 13.3.3 AUTO CODING 242 13.3.3.1 Elevating use of AI tools to improve claim reimbursement process to fuel market growth 242 13.3.4 CLASSIFICATION & CATEGORIZATION 243 13.3.4.1 Business need to organize and classify healthcare data efficiently to expand AI implementation 243 13.3.5 TEXT ANALYTICS 244 13.3.5.1 Necessity to derive insights from unstructured clinical text to enhance use of text analytics 244   13.3.6 SPEECH RECOGNITION 244 13.3.6.1 Rising focus on reducing physician administrative burden to accelerate demand 244 13.4 CONTEXT-AWARE COMPUTING 245 13.4.1 DEVICE CONTEXT 246 13.4.1.1 Integration of connected medical devices to boost demand for intelligent device-aware healthcare applications 246 13.4.2 USER CONTEXT 247 13.4.2.1 Rising focus on individualized clinical decision support to spike demand 247 13.4.3 PHYSICAL CONTEXT 248 13.4.3.1 Increasing adoption of AI for real-time environmental and patient context monitoring to generate demand 248 13.5 GENERATIVE AI 249 13.5.1 INCREASING USE OF GENERATIVE MODELS TO OFFER TAILORED INTERVENTIONS TO DRIVE MARKET 249 13.6 COMPUTER VISION 249 13.6.1 ABILITY TO DETECT ABNORMALITIES SUCH AS TUMORS AND FRACTURES TO FUEL ADOPTION 249 13.7 IMAGE ANALYSIS 251 13.7.1 GROWING ADOPTION OF AI FOR EARLY DISEASE DETECTION AND DIAGNOSIS TO CONTRIBUTE TO MARKT GROWTH 251 14 AI IN HEALTHCARE MARKET, BY END USER 252 14.1 INTRODUCTION 253 14.2 HEALTHCARE PROVIDERS 253 14.2.1 HOSPITALS & CLINICS 255 14.2.1.1 Increasing focus on enhancing patient outcomes through AI to expedite market expansion 255 14.2.2 AMBULATORY CARE CENTERS 256 14.2.2.1 Rising adoption of AI to reduce care delivery costs to reinforce market growth 256 14.2.3 HOME HEALTHCARE AGENCIES & ASSISTED-LIVING FACILITIES 257 14.2.3.1 Escalating demand for personalized and continuous patient care to accelerate market growth 257 14.2.4 DIAGNOSTIC & IMAGING CENTERS 258 14.2.4.1 Increasing partnerships between hospitals and imaging centers to develop regulatory-cleared AI tools to support market growth 258 14.2.5 PHARMACIES 259 14.2.5.1 Heightened need for AI-driven inventory optimization to unlock opportunities 259 14.2.6 OTHER HEALTHCARE PROVIDERS 260   14.3 HEALTHCARE PAYERS 260 14.3.1 PUBLIC PAYERS 262 14.3.1.1 Increasing focus on cost optimization and fraud prevention to promote adoption of AI by public payers 262 14.3.2 PRIVATE PAYERS 263 14.3.2.1 Leveraging AI to optimize claims management, member engagement, and value-based care programs to drive market 263 14.4 PATIENTS 264 14.4.1 INCREASING ADOPTION OF AI FOR PATIENT ENGAGEMENT AND SELF-CARE TO FACILITATE MARKET GROWTH 264 14.5 OTHER END USERS 265 15 AI IN HEALTHCARE MARKET, BY REGION 266 15.1 INTRODUCTION 267 15.2 NORTH AMERICA 267 15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 269 15.2.2 US 284 15.2.2.1 Increasing focus on personalized medicine and precision healthcare to drive market 284 15.2.3 CANADA 298 15.2.3.1 Rising use of AI to improve disease care and patient survival and clinical workflows to drive market 298 15.3 EUROPE 312 15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 312 15.3.2 GERMANY 327 15.3.2.1 Collaborative health-related research and innovation programs and initiatives to contribute to market growth 327 15.3.3 UK 340 15.3.3.1 Significant focus of government on early diagnosis, personalized treatments, and rapid drug development to boost AI demand 340 15.3.4 FRANCE 354 15.3.4.1 Expanding AI-enabled digital healthcare and patient services to foster market growth 354 15.3.5 ITALY 368 15.3.5.1 Growing deployment of AI infrastructure to ensure transparency, data protection, and patient safety to facilitate market growth 368 15.3.6 SPAIN 382 15.3.6.1 Partnerships between scientists, medical professionals, and AI experts to develop innovative diagnostic tools to drive market 382 15.3.7 REST OF EUROPE 395   15.4 ASIA PACIFIC 410 15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 411 15.4.2 CHINA 424 15.4.2.1 Growing focus on healthcare innovation through national AI initiatives to accelerate market growth 424 15.4.3 JAPAN 438 15.4.3.1 Strong healthcare infrastructure to drive adoption of advanced AI 438 15.4.4 INDIA 450 15.4.4.1 Strong government support for digital health initiatives to create lucrative opportunities 450 15.4.5 AUSTRALIA 464 15.4.5.1 Strong research ecosystem and national digital health initiatives to drive market 464 15.4.6 SOUTH KOREA 477 15.4.6.1 National Strategy for Artificial Intelligence and Digital Healthcare Innovation Plan initiatives to support market growth 477 15.4.7 REST OF ASIA PACIFIC 490 15.5 LATIN AMERICA 504 15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 504 15.5.2 BRAZIL 517 15.5.2.1 Expanding digital health infrastructure and growing adoption of AI-enabled healthcare technologies to foster market growth 517 15.5.3 MEXICO 530 15.5.3.1 Growing adoption of AI-driven chronic disease management platforms to stimulate market growth 530 15.5.4 REST OF LATIN AMERICA 543 15.6 MIDDLE EAST & AFRICA 556 15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 557 15.6.2 GCC 570 15.6.2.1 Saudi Arabia 583 15.6.2.1.1 Accelerating AI-driven healthcare transformation under Saudi Vision 2030 to contribute to market growth 583 15.6.2.2 UAE 596 15.6.2.2.1 Rising focus on improving healthcare quality and delivering personalized patient care to reinforce market growth 596 15.6.2.3 Rest of GCC 609 15.6.3 SOUTH AFRICA 622 15.6.3.1 Expanding use of AI to enhance medical imaging, clinical decision support, and disease surveillance to drive market 622 15.6.4 REST OF MIDDLE EAST & AFRICA 635   16 COMPETITIVE LANDSCAPE 649 16.1 INTRODUCTION 649 16.2 KEY PLAYER COMPETITIVE STRATEGY/RIGHT TO WIN, JANUARY 2023 TO JUNE 2026 649 16.3 REVENUE ANALYSIS, 2021–2025 652 16.4 MARKET SHARE ANALYSIS, 2025 653 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 655 16.5.1 STARS 655 16.5.2 EMERGING LEADERS 655 16.5.3 PERVASIVE PLAYERS 655 16.5.4 PARTICIPANTS 655 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 657 16.5.5.1 Company footprint 657 16.5.5.2 Region footprint 658 16.5.5.3 Application footprint 659 16.5.5.4 Tool footprint 660 16.5.5.5 Function footprint 661 16.5.5.6 Offering footprint 662 16.5.5.7 Deployment footprint 663 16.5.5.8 End user footprint 664 16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 665 16.6.1 PROGRESSIVE COMPANIES 665 16.6.2 RESPONSIVE COMPANIES 665 16.6.3 DYNAMIC COMPANIES 665 16.6.4 STARTING BLOCKS 665 16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 667 16.6.5.1 Detailed list of key startups/SMEs 667 16.6.5.2 Company footprint (startups/SMEs) 667 16.7 COMPANY VALUATION AND FINANCIAL METRICS 668 16.7.1 FINANCIAL METRICS 668 16.7.2 COMPANY VALUATION 668 16.8 BRAND/PRODUCT COMPARISON 669 16.9 COMPETITIVE SCENARIO 669 16.9.1 PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 669 16.9.2 DEALS 671 16.9.3 OTHER DEVELOPMENTS 672   17 COMPANY PROFILES 673 17.1 KEY PLAYERS 673 17.1.1 KONINKLIJKE PHILIPS N.V. 673 17.1.1.1 Business overview 673 17.1.1.2 Products & services offered 674 17.1.1.3 Recent developments 676 17.1.1.3.1 Product launches/enhancements/approvals 676 17.1.1.3.2 Deals 678 17.1.1.3.3 Expansions 680 17.1.1.3.4 Other developments 681 17.1.1.4 MnM view 681 17.1.1.4.1 Right to win 681 17.1.1.4.2 Strategic choices 681 17.1.1.4.3 Weaknesses & competitive threats 681 17.1.2 MICROSOFT CORPORATION 682 17.1.2.1 Business overview 682 17.1.2.2 Products & services offered 683 17.1.2.3 Recent developments 685 17.1.2.3.1 Product launches/enhancements/approvals 685 17.1.2.3.2 Deals 686 17.1.2.4 MnM view 688 17.1.2.4.1 Right to win 688 17.1.2.4.2 Strategic choices 688 17.1.2.4.3 Weaknesses & competitive threats 688 17.1.3 NVIDIA CORPORATION 689 17.1.3.1 Business overview 689 17.1.3.2 Products & services offered 690 17.1.3.3 Recent developments 691 17.1.3.3.1 Product launches/enhancements/approvals 691 17.1.3.3.2 Deals 692 17.1.3.4 MnM view 694 17.1.3.4.1 Right to win 694 17.1.3.4.2 Strategic choices 694 17.1.3.4.3 Weaknesses & competitive threats 694 17.1.4 SIEMENS HEALTHINEERS AG 695 17.1.4.1 Business overview 695 17.1.4.2 Products & services offered 696 17.1.4.3 Recent developments 698 17.1.4.3.1 Product launches/enhancements/approvals 698 17.1.4.3.2 Deals 699   17.1.4.4 MnM view 700 17.1.4.4.1 Right to win 700 17.1.4.4.2 Strategic choices 701 17.1.4.4.3 Weaknesses & competitive threats 701 17.1.5 GE HEALTHCARE 702 17.1.5.1 Business overview 702 17.1.5.2 Products & services offered 703 17.1.5.3 Recent developments 705 17.1.5.3.1 Product launches/enhancements/approvals 705 17.1.5.3.2 Deals 705 17.1.5.3.3 Other developments 707 17.1.5.4 MnM view 707 17.1.5.4.1 Right to win 707 17.1.5.4.2 Strategic choices 707 17.1.5.4.3 Weaknesses & competitive threats 707 17.1.6 EPIC SYSTEMS CORPORATION 708 17.1.6.1 Business overview 708 17.1.6.2 Products & services offered 708 17.1.6.3 Recent developments 709 17.1.6.3.1 Product launches/enhancements/approvals 709 17.1.6.3.2 Deals 709 17.1.7 ORACLE 710 17.1.7.1 Business overview 710 17.1.7.2 Products & services offered 711 17.1.7.3 Recent developments 712 17.1.7.3.1 Product launches/enhancements/approvals 712 17.1.7.3.2 Deals 713 17.1.7.3.3 Expansions 714 17.1.8 VERADIGM INC. 715 17.1.8.1 Business overview 715 17.1.8.2 Products & services offered 715 17.1.8.3 Recent developments 716 17.1.8.3.1 Product launches/enhancements/approvals 716 17.1.8.3.2 Deals 717 17.1.9 AMAZON WEB SERVICES, INC. 718 17.1.9.1 Business overview 718 17.1.9.2 Products & services offered 719 17.1.9.3 Recent developments 720 17.1.9.3.1 Product launches/enhancements/approvals 720 17.1.9.3.2 Deals 721 17.1.9.3.3 Expansions 722   17.1.10 MERATIVE 723 17.1.10.1 Business overview 723 17.1.10.2 Products & services offered 723 17.1.10.3 Recent developments 724 17.1.10.3.1 Product launches/enhancements/approvals 724 17.1.10.3.2 Deals 724 17.1.11 IBM 725 17.1.11.1 Business overview 725 17.1.11.2 Products & services offered 726 17.1.11.3 Recent developments 727 17.1.11.3.1 Deals 727 17.1.12 MEDTRONIC 728 17.1.12.1 Business overview 728 17.1.12.2 Products & services offered 729 17.1.12.3 Recent developments 730 17.1.12.3.1 Product launches/enhancements/approvals 730 17.1.12.3.2 Deals 731 17.1.13 GOOGLE 732 17.1.13.1 Business overview 732 17.1.13.2 Products & services offered 733 17.1.13.3 Recent developments 735 17.1.13.3.1 Product launches/enhancements/approvals 735 17.1.13.3.2 Deals 736 17.1.13.3.3 Other developments 738 17.1.14 SOPHIA GENETICS 739 17.1.14.1 Business overview 739 17.1.14.2 Products & services offered 740 17.1.14.3 Recent developments 740 17.1.14.3.1 Product launches/enhancements/approvals 740 17.1.14.3.2 Deals 741 17.1.14.3.3 Other developments 742 17.1.15 JOHNSON & JOHNSON SERVICES, INC. 743 17.1.15.1 Business overview 743 17.1.15.2 Products & services offered 744 17.1.15.3 Recent developments 745 17.1.15.3.1 Product launches/enhancements/approvals 745 17.1.15.3.2 Deals 745 17.1.16 TEMPUS AI, INC. 746 17.1.16.1 Business overview 746 17.1.16.2 Products & services offered 747 17.1.16.3 Recent developments 748 17.1.16.3.1 Product launches/enhancements/approvals 748 17.1.16.3.2 Deals 749 17.1.17 CONCERTAI 751 17.1.17.1 Business overview 751 17.1.17.2 Products & services offered 751 17.1.17.3 Recent developments 752 17.1.17.3.1 Product launches/enhancements/approvals 752 17.1.17.3.2 Deals 753 17.1.18 SOLVENTUM CORPORATION 755 17.1.18.1 Business overview 755 17.1.18.2 Products & services offered 756 17.1.18.3 Recent developments 757 17.1.18.3.1 Deals 757 17.1.18.3.2 Other developments 758 17.1.19 COGNIZANT 759 17.1.19.1 Business overview 759 17.1.19.2 Products & services offered 760 17.1.19.3 Recent developments 761 17.1.19.3.1 Product launches/enhancements/approvals 761 17.1.19.3.2 Deals 762 17.1.20 VIZ.AI, INC. 763 17.1.20.1 Business overview 763 17.1.20.2 Products & services offered 763 17.1.20.3 Recent developments 764 17.1.20.3.1 Product launches/enhancements/approvals 764 17.1.20.3.2 Deals 764 17.1.20.3.3 Other developments 766 17.1.21 RIVERAIN TECHNOLOGIES 767 17.1.21.1 Business overview 767 17.1.21.2 Products & services offered 767 17.1.21.3 Recent developments 768 17.1.21.3.1 Product launches/enhancements/approvals 768 17.1.21.3.2 Deals 768 17.2 OTHER PLAYERS 770 17.2.1 QVENTUS 770 17.2.2 QURE.AI 771 17.2.3 SUKI AI, INC. 772 17.2.4 ENLITIC 773 17.2.5 SEGMED 773   18 RESEARCH METHODOLOGY 774 18.1 RESEARCH DATA 774 18.1.1 SECONDARY DATA 775 18.1.1.1 Key data from secondary sources 776 18.1.2 PRIMARY DATA 776 18.1.2.1 Key data from primary sources 778 18.1.2.2 Key industry insights 778 18.2 MARKET SIZE ESTIMATION 779 18.3 DATA TRIANGULATION 784 18.4 MARKET SHARE ESTIMATION 785 18.5 RESEARCH ASSUMPTIONS 785 18.6 RESEARCH LIMITATIONS 785 18.6.1 METHODOLOGY-RELATED LIMITATIONS 785 18.6.2 SCOPE-RELATED LIMITATIONS 785 18.7 RISK ASSESSMENT 786 19 APPENDIX 787 19.1 DISCUSSION GUIDE 787 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 794 19.3 CUSTOMIZATION OPTIONS 796 19.4 RELATED REPORTS 796 19.5 AUTHOR DETAILS 797
圖表清單 List of Tables & Figures
TABLE 1 INCLUSIONS AND EXCLUSIONS 68 TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 72 TABLE 3 AI IN HEALTHCARE MARKET: IMPACT ANALYSIS 82 TABLE 4 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 94 TABLE 5 AI IN HEALTHCARE MARKET: ROLE IN ECOSYSTEM 100 TABLE 6 INDICATIVE PRICING FOR AI IN HEALTHCARE, BY NON-CLINICAL APPLICATION (2025) 101 TABLE 7 INDICATIVE PRICING FOR AI IN HEALTHCARE, BY CLINICAL APPLICATION (2025) 101 TABLE 8 CASE 1: AI-ENABLED LUNG CANCER DIAGNOSIS IN NHS HOSPITALS 104 TABLE 9 CASE 2: AI-DRIVEN PATIENT ENGAGEMENT IN CHILDREN'S HEALTHCARE 104 TABLE 10 CASE 3: DIGITAL PATIENT ENGAGEMENT AT SPARTA COMMUNITY HOSPITAL 105 TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES 106 TABLE 12 EXPECTED CHANGE IN PRICES AND LIKELY IMPACT ON END-USE MARKET DUE TO TARIFF IMPACT 107 TABLE 13 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI IN HEALTHCARE SECTOR 114 TABLE 14 AI IN HEALTHCARE MARKET: LIST OF PATENTS/PATENT APPLICATIONS, 2022–2024 115 TABLE 15 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 118 TABLE 16 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 119 TABLE 17 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 119 TABLE 18 NORTH AMERICA 120 TABLE 19 EUROPE 121 TABLE 20 ASIA PACIFIC 121 TABLE 21 MIDDLE EAST & AFRICA 122 TABLE 22 LATIN AMERICA 123 TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP 3 END USERS (%) 125 TABLE 24 KEY BUYING CRITERIA FOR TOP 3 END USERS 126 TABLE 25 UNMET NEEDS IN AI IN HEALTHCARE MARKET 127 TABLE 26 END-USER EXPECTATIONS IN AI IN HEALTHCARE MARKET 128 TABLE 27 EXPECTED CHANGE IN PRICES AND ANTICIPATED IMPACT ON END USERS DUE TO TARIFF IMPACT 129 TABLE 28 AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 134 TABLE 29 AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 135 TABLE 30 AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY REGION, 2024–2031 (USD MILLION) 135 TABLE 31 AI IN HEALTHCARE MARKET FOR PRE-SCREENING, BY REGION, 2024–2031 (USD MILLION) 136 TABLE 32 AI IN HEALTHCARE MARKET FOR IVD, BY REGION, 2024–2031 (USD MILLION) 137 TABLE 33 AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 137 TABLE 34 AI IN HEALTHCARE MARKET FOR IMMUNOASSAYS, BY REGION, 2024–2031 (USD MILLION) 138 TABLE 35 AI IN HEALTHCARE MARKET FOR CLINICAL CHEMISTRY, BY REGION, 2024–2031 (USD MILLION) 139 TABLE 36 AI IN HEALTHCARE MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2024–2031 (USD MILLION) 140 TABLE 37 AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 140 TABLE 38 AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS & INTERPRETATION, BY REGION, 2024–2031 (USD MILLION) 141 TABLE 39 AI IN HEALTHCARE MARKET FOR BIOMARKER DISCOVERY & ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 142 TABLE 40 AI IN HEALTHCARE MARKET FOR OTHER IVD APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 143 TABLE 41 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY REGION, 2024–2031 (USD MILLION) 143 TABLE 42 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 144 TABLE 43 AI IN HEALTHCARE MARKET FOR DISEASE INTERPRETATION & REPORT ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 145 TABLE 44 AI IN HEALTHCARE MARKET FOR IMAGE CAPTIONING & ANNOTATION, BY REGION, 2024–2031 (USD MILLION) 146 TABLE 45 AI IN HEALTHCARE MARKET FOR IMAGE RECONSTRUCTION, BY REGION, 2024–2031 (USD MILLION) 147 TABLE 46 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING, BY REGION, 2024–2031 (USD MILLION) 147 TABLE 47 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 148 TABLE 48 AI IN HEALTHCARE MARKET FOR MAGNETIC RESONANCE IMAGING, BY REGION, 2024–2031 (USD MILLION) 149 TABLE 49 AI IN HEALTHCARE MARKET FOR COMPUTED TOMOGRAPHY, BY REGION, 2024–2031 (USD MILLION) 150 TABLE 50 AI IN HEALTHCARE MARKET FOR X-RAY IMAGING, BY REGION, 2024–2031 (USD MILLION) 151 TABLE 51 AI IN HEALTHCARE MARKET FOR ULTRASOUND, BY REGION, 2024–2031 (USD MILLION) 152 TABLE 52 AI IN HEALTHCARE MARKET FOR NUCLEAR IMAGING, BY REGION, 2024–2031 (USD MILLION) 153 TABLE 53 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING MODALITIES, BY REGION, 2024–2031 (USD MILLION) 153 TABLE 54 AI IN HEALTHCARE MARKET FOR RISK ASSESSMENT & PATIENT STRATIFICATION, BY REGION, 2024–2031 (USD MILLION) 154 TABLE 55 AI IN HEALTHCARE MARKET FOR DRUG ALLERGY ALERTING, BY REGION, 2024–2031 (USD MILLION) 155 TABLE 56 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY REGION, 2024–2031 (USD MILLION) 156 TABLE 57 AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 156 TABLE 58 AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY REGION, 2024–2031 (USD MILLION) 157 TABLE 59 AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 158 TABLE 60 AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY REGION, 2024–2031 (USD MILLION) 158 TABLE 61 AI IN HEALTHCARE MARKET FOR PRECISION MEDICINE & GENOMIC ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 159 TABLE 62 AI IN HEALTHCARE MARKET FOR PREDICTIVE MODELS FOR TREATMENT RESPONSE, BY REGION, 2024–2031 (USD MILLION) 160 TABLE 63 AI IN HEALTHCARE MARKET FOR TREATMENT RECOMMENDATION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 161 TABLE 64 AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 161 TABLE 65 AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY REGION, 2024–2031 (USD MILLION) 162 TABLE 66 AI IN HEALTHCARE MARKET FOR DRUG RESPONSE PREDICTION, BY REGION, 2024–2031 (USD MILLION) 163 TABLE 67 AI IN HEALTHCARE MARKET FOR DOSING & ADMINISTRATION, BY REGION, 2024–2031 (USD MILLION) 164 TABLE 68 AI IN HEALTHCARE MARKET FOR OTHER PHARMACOLOGICAL THERAPY FUNCTIONS, BY REGION, 2024–2031 (USD MILLION) 164 TABLE 69 AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 165 TABLE 70 AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY REGION, 2024–2031 (USD MILLION) 165 TABLE 71 AI IN HEALTHCARE MARKET FOR PREOPERATIVE IMAGING & 3D MODELING, BY REGION, 2024–2031 (USD MILLION) 166 TABLE 72 AI IN HEALTHCARE MARKET FOR INTRAOPERATIVE GUIDANCE & ROBOTICS, BY REGION, 2024–2031 (USD MILLION) 167 TABLE 73 AI IN HEALTHCARE MARKET FOR POSTOPERATIVE ANALYSIS & RECOVERY, BY REGION, 2024–2031 (USD MILLION) 168 TABLE 74 AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 169 TABLE 75 AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY REGION, 2024–2031 (USD MILLION) 169 TABLE 76 AI IN HEALTHCARE MARKET FOR MOTION SYNCHRONIZATION & AUTO CONTOURING, BY REGION, 2024–2031 (USD MILLION) 170 TABLE 77 AI IN HEALTHCARE MARKET FOR REAL-TIME ADAPTIVE TREATMENT DELIVERY, BY REGION, 2024–2031 (USD MILLION) 171 TABLE 78 AI IN HEALTHCARE MARKET FOR RESPONSE ASSESSMENT & QUALITY ASSURANCE, BY REGION, 2024–2031 (USD MILLION) 172 TABLE 79 AI IN HEALTHCARE MARKET FOR OTHER RADIATION THERAPY FUNCTIONS, BY REGION, 2024–2031 (USD MILLION) 172 TABLE 80 AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 173 TABLE 81 AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY REGION, 2024–2031 (USD MILLION) 173 TABLE 82 AI IN HEALTHCARE MARKET FOR VIRTUAL COUNSELING & CHATBOTS, BY REGION, 2024–2031 (USD MILLION) 174 TABLE 83 AI IN HEALTHCARE MARKET FOR PROGRESS MONITORING & FEEDBACK, BY REGION, 2024–2031 (USD MILLION) 175 TABLE 84 AI IN HEALTHCARE MARKET FOR FOLLOW-UP & LONG-TERM SUPPORT, BY REGION, 2024–2031 (USD MILLION) 176 TABLE 85 AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 177 TABLE 86 AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY REGION, 2024–2031 (USD MILLION) 177 TABLE 87 AI IN HEALTHCARE MARKET FOR REAL-TIME PATIENT DATA MONITORING, BY REGION, 2024–2031 (USD MILLION) 178 TABLE 88 AI IN HEALTHCARE MARKET FOR RESPONSE & SIDE-EFFECT PREDICTION, BY REGION, 2024–2031 (USD MILLION) 179 TABLE 89 AI IN HEALTHCARE MARKET FOR RELAPSE PREDICTION & LONG-TERM MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 180 TABLE 90 AI IN HEALTHCARE MARKET FOR OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2024–2031 (USD MILLION) 180 TABLE 91 AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 181 TABLE 92 AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY REGION, 2024–2031 (USD MILLION) 182 TABLE 93 AI IN HEALTHCARE MARKET FOR SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE, BY REGION, 2024–2031 (USD MILLION) 183 TABLE 94 AI IN HEALTHCARE MARKET FOR TELEHEALTH & REMOTE PATIENT MONITORING, BY REGION, 2024–2031 (USD MILLION) 184 TABLE 95 AI IN HEALTHCARE MARKET FOR HEALTHCARE ASSISTANCE ROBOTS, BY REGION, 2024–2031 (USD MILLION) 185 TABLE 96 AI IN HEALTHCARE MARKET FOR MEDICATION REMINDERS, BY REGION, 2024–2031 (USD MILLION) 186 TABLE 97 AI IN HEALTHCARE MARKET FOR PATIENT EDUCATION & EMPOWERMENT, BY REGION, 2024–2031 (USD MILLION) 187 TABLE 98 AI IN HEALTHCARE MARKET FOR OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2024–2031 (USD MILLION) 187 TABLE 99 AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 188 TABLE 100 AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY REGION, 2024–2031 (USD MILLION) 188 TABLE 101 AI IN HEALTHCARE MARKET FOR RECURRENCE MONITORING, BY REGION, 2024–2031 (USD MILLION) 189 TABLE 102 AI IN HEALTHCARE MARKET FOR LONG-TERM OUTCOME PREDICTION, BY REGION, 2024–2031 (USD MILLION) 190 TABLE 103 AI IN HEALTHCARE MARKET FOR MENTAL HEALTH & SUPPORT SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 191 TABLE 104 AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 191 TABLE 105 AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY REGION, 2 024–2031 (USD MILLION) 192 TABLE 106 AI IN HEALTHCARE MARKET FOR EPRESCRIBING, BY REGION, 2024–2031 (USD MILLION) 193 TABLE 107 AI IN HEALTHCARE MARKET FOR MEDICATION MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 194 TABLE 108 AI IN HEALTHCARE MARKET FOR PHARMACY AUDIT & ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 195 TABLE 109 AI IN HEALTHCARE MARKET FOR OTHER PHARMACY MANAGEMENT FUNCTIONS, BY REGION, 2024–2031 (USD MILLION) 195 TABLE 110 AI IN HEALTHCARE MARKET FOR DATA MANAGEMENT & ANALYTICS FUNCTIONS, BY REGION, 2024–2031 (USD MILLION) 196 TABLE 111 AI IN HEALTHCARE MARKET FOR AI SCRIBE, BY REGION, 2024–2031 (USD MILLION) 197 TABLE 112 AI IN HEALTHCARE MARKET FOR CLINICAL DECISION SUPPORT SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 198 TABLE 113 AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 199 TABLE 114 AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY REGION, 2024–2031 (USD MILLION) 199 TABLE 115 AI IN HEALTHCARE MARKET FOR PATIENT REGISTRATION & SCHEDULING, BY REGION, 2024–2031 (USD MILLION) 200 TABLE 116 AI IN HEALTHCARE MARKET FOR PATIENT ELIGIBILITY & AUTHORIZATION, BY REGION, 2024–2031 (USD MILLION) 201 TABLE 117 AI IN HEALTHCARE MARKET FOR REVENUE CYCLE MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 202 TABLE 118 AI IN HEALTHCARE MARKET FOR WORKFORCE MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 203 TABLE 119 AI IN HEALTHCARE MARKET FOR SUPPLY CHAIN & INVENTORY MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 204 TABLE 120 AI IN HEALTHCARE MARKET FOR COMPLIANCE & DOCUMENTATION, BY REGION, 2024–2031 (USD MILLION) 205 TABLE 121 AI IN HEALTHCARE MARKET FOR HEALTHCARE WORKFLOW MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 206 TABLE 122 AI IN HEALTHCARE MARKET FOR ASSET MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 207 TABLE 123 AI IN HEALTHCARE MARKET FOR CUSTOMER RELATIONSHIP MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 208 TABLE 124 AI IN HEALTHCARE MARKET FOR FRAUD DETECTION & RISK MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 209 TABLE 125 AI IN HEALTHCARE MARKET FOR CYBERSECURITY, BY REGION, 2024–2031 (USD MILLION) 210 TABLE 126 AI IN HEALTHCARE MARKET FOR OTHER ADMINISTRATIVE FUNCTIONS, BY REGION, 2024–2031 (USD MILLION) 210 TABLE 127 AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 212 TABLE 128 AI IN HEALTHCARE MARKET FOR INTEGRATED SOLUTIONS, BY REGION, 2024–2031 (USD MILLION) 213 TABLE 129 AI IN HEALTHCARE MARKET FOR NICHE/POINT SOLUTIONS, BY REGION, 2024–2031 (USD MILLION) 214 TABLE 130 AI IN HEALTHCARE MARKET FOR AI TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION) 215 TABLE 131 AI IN HEALTHCARE MARKET FOR SERVICES, BY REGION, 2024–2031 (USD MILLION) 216 TABLE 132 AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 218 TABLE 133 AI IN HEALTHCARE MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 219 TABLE 134 AI IN HEALTHCARE MARKET FOR NON-CLINICAL APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 221 TABLE 135 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 223 TABLE 136 AI IN HEALTHCARE MARKET FOR ON-PREMISES MODEL, BY REGION, 2024–2031 (USD MILLION) 224 TABLE 137 AI IN HEALTHCARE MARKET FOR CLOUD-BASED MODEL, BY REGION, 2024–2031 (USD MILLION) 225 TABLE 138 AI IN HEALTHCARE MARKET FOR HYBRID MODEL, BY REGION, 2024–2031 (USD MILLION) 226 TABLE 139 AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 228 TABLE 140 AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 229 TABLE 141 AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY REGION, 2024–2031 (USD MILLION) 229 TABLE 142 AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 231 TABLE 143 AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY REGION, 2024–2031 (USD MILLION) 231 TABLE 144 AI IN HEALTHCARE MARKET FOR CONVOLUTIONAL NEURAL NETWORKS, BY REGION, 2024–2031 (USD MILLION) 232 TABLE 145 AI IN HEALTHCARE MARKET FOR RECURRENT NEURAL NETWORKS, BY REGION, 2024–2031 (USD MILLION) 233 TABLE 146 AI IN HEALTHCARE MARKET FOR GENERATIVE ADVERSARIAL NETWORKS, BY REGION, 2024–2031 (USD MILLION) 234 TABLE 147 AI IN HEALTHCARE MARKET FOR GRAPH NEURAL NETWORKS, BY REGION, 2024–2031 (USD MILLION) 235 TABLE 148 AI IN HEALTHCARE MARKET FOR OTHER DEEP LEARNING TOOLS, BY REGION, 2024–2031 (USD MILLION) 235 TABLE 149 AI IN HEALTHCARE MARKET FOR SUPERVISED LEARNING, BY REGION, 2024–2031 (USD MILLION) 236 TABLE 150 AI IN HEALTHCARE MARKET FOR REINFORCEMENT LEARNING, BY REGION, 2024–2031 (USD MILLION) 237 TABLE 151 AI IN HEALTHCARE MARKET FOR UNSUPERVISED LEARNING, BY REGION, 2024–2031 (USD MILLION) 238 TABLE 152 AI IN HEALTHCARE MARKET FOR OTHER MACHINE LEARNING TOOLS, BY REGION, 2024–2031 (USD MILLION) 239 TABLE 153 AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 240 TABLE 154 AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY REGION, 2024–2031 (USD MILLION) 240 TABLE 155 AI IN HEALTHCARE MARKET FOR SENTIMENT ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 241 TABLE 156 AI IN HEALTHCARE MARKET FOR PATTERN & IMAGE RECOGNITION, BY REGION, 2024–2031 (USD MILLION) 242 TABLE 157 AI IN HEALTHCARE MARKET FOR AUTO CODING, BY REGION, 2024–2031 (USD MILLION) 243 TABLE 158 AI IN HEALTHCARE MARKET FOR CLASSIFICATION & CATEGORIZATION, BY REGION, 2024–2031 (USD MILLION) 243 TABLE 159 AI IN HEALTHCARE MARKET FOR TEXT ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 244 TABLE 160 AI IN HEALTHCARE MARKET FOR SPEECH RECOGNITION, BY REGION, 2024–2031 (USD MILLION) 245 TABLE 161 AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 246 TABLE 162 AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY REGION, 2024–2031 (USD MILLION) 246 TABLE 163 AI IN HEALTHCARE MARKET FOR DEVICE CONTEXT, BY REGION, 2024–2031 (USD MILLION) 247 TABLE 164 AI IN HEALTHCARE MARKET FOR USER CONTEXT, BY REGION, 2024–2031 (USD MILLION) 248 TABLE 165 AI IN HEALTHCARE MARKET FOR PHYSICAL CONTEXT, BY REGION, 2024–2031 (USD MILLION) 248 TABLE 166 AI IN HEALTHCARE MARKET FOR GENERATIVE AI, BY REGION, 2024–2031 (USD MILLION) 249 TABLE 167 AI IN HEALTHCARE MARKET FOR COMPUTER VISION, BY REGION, 2024–2031 (USD MILLION) 250 TABLE 168 AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 251 TABLE 169 AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 253 TABLE 170 AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 254 TABLE 171 AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2024–2031 (USD MILLION) 255 TABLE 172 AI IN HEALTHCARE MARKET FOR HOSPITALS & CLINICS, BY REGION, 2024–2031 (USD MILLION) 256 TABLE 173 AI IN HEALTHCARE MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2024–2031 (USD MILLION) 257 TABLE 174 AI IN HEALTHCARE MARKET FOR HOME HEALTHCARE AGENCIES & ASSISTED-LIVING FACILITIES, BY REGION, 2024–2031 (USD MILLION) 258 TABLE 175 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2024–2031 (USD MILLION) 259 TABLE 176 AI IN HEALTHCARE MARKET FOR PHARMACIES, BY REGION, 2024–2031 (USD MILLION) 260 TABLE 177 AI IN HEALTHCARE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2024–2031 (USD MILLION) 260 TABLE 178 AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 261 TABLE 179 AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2024–2031 (USD MILLION) 261 TABLE 180 AI IN HEALTHCARE MARKET FOR PUBLIC PAYERS, BY REGION, 2024–2031 (USD MILLION) 262 TABLE 181 AI IN HEALTHCARE MARKET FOR PRIVATE PAYERS, BY REGION, 2024–2031 (USD MILLION) 263 TABLE 182 AI IN HEALTHCARE MARKET FOR PATIENTS, BY REGION, 2024–2031 (USD MILLION) 264 TABLE 183 AI IN HEALTHCARE MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 265 TABLE 184 AI IN HEALTHCARE MARKET, BY REGION, 2024–2031 (USD MILLION) 267 TABLE 185 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 270 TABLE 186 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 270 TABLE 187 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 271 TABLE 188 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 189 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 272 TABLE 190 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 272 TABLE 191 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 273 TABLE 192 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 273 TABLE 193 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 274 TABLE 194 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 274 TABLE 195 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 275 TABLE 196 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 275 TABLE 197 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 198 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 199 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 200 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 201 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 278 TABLE 202 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 278 TABLE 203 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 279 TABLE 204 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 279 TABLE 205 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 280 TABLE 206 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 280 TABLE 207 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 208 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 209 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 282 TABLE 210 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 282 TABLE 211 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 283 TABLE 212 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 283 TABLE 213 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 214 US: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 285 TABLE 215 US: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 285 TABLE 216 US: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 286 TABLE 217 US: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 286 TABLE 218 US: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 287 TABLE 219 US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 287 TABLE 220 US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 288 TABLE 221 US: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 222 US: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 223 US: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 224 US: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 290 TABLE 225 US: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 290 TABLE 226 US: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 227 US: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 228 US: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 229 US: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 230 US: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 231 US: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 232 US: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 294 TABLE 233 US: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 294 TABLE 234 US: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 294 TABLE 235 US: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 295 TABLE 236 US: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 295 TABLE 237 US: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 296 TABLE 238 US: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 296 TABLE 239 US: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 297 TABLE 240 US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 241 US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 242 CANADA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 299 TABLE 243 CANADA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 299 TABLE 244 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 245 CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 300 TABLE 246 CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 301 TABLE 247 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 301 TABLE 248 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 302 TABLE 249 CANADA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 250 CANADA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 251 CANADA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 252 CANADA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 304 TABLE 253 CANADA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 304 TABLE 254 CANADA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 305 TABLE 255 CANADA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 305 TABLE 256 CANADA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 257 CANADA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 258 CANADA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 259 CANADA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 260 CANADA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 308 TABLE 261 CANADA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 308 TABLE 262 CANADA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 308 TABLE 263 CANADA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 309 TABLE 264 CANADA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 309 TABLE 265 CANADA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 266 CANADA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 267 CANADA: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 311 TABLE 268 CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 311 TABLE 269 CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 312 TABLE 270 EUROPE: AI IN HEALTHCARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 313 TABLE 271 EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 313 TABLE 272 EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 314 TABLE 273 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 314 TABLE 274 EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 315 TABLE 275 EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 315 TABLE 276 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 316 TABLE 277 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 316 TABLE 278 EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 317 TABLE 279 EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 317 TABLE 280 EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 281 EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 282 EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 283 EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 284 EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 320 TABLE 285 EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 320 TABLE 286 EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 321 TABLE 287 EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 321 TABLE 288 EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 322 TABLE 289 EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 322 TABLE 290 EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 323 TABLE 291 EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 323 TABLE 292 EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 324 TABLE 293 EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 324 TABLE 294 EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 325 TABLE 295 EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 325 TABLE 296 EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 326 TABLE 297 EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 326 TABLE 298 EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 327 TABLE 299 GERMANY: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 328 TABLE 300 GERMANY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 328 TABLE 301 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 329 TABLE 302 GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 329 TABLE 303 GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 330 TABLE 304 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 330 TABLE 305 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 331 TABLE 306 GERMANY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 331 TABLE 307 GERMANY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 332 TABLE 308 GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 332 TABLE 309 GERMANY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 333 TABLE 310 GERMANY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 333 TABLE 311 GERMANY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 334 TABLE 312 GERMANY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 334 TABLE 313 GERMANY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 335 TABLE 314 GERMANY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 335 TABLE 315 GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 336 TABLE 316 GERMANY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 336 TABLE 317 GERMANY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 337 TABLE 318 GERMANY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 337 TABLE 319 GERMANY: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 337 TABLE 320 GERMANY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 338 TABLE 321 GERMANY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 338 TABLE 322 GERMANY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 339 TABLE 323 GERMANY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 339 TABLE 324 GERMANY: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 339 TABLE 325 GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 340 TABLE 326 GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 340 TABLE 327 UK: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 341 TABLE 328 UK: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 342 TABLE 329 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 342 TABLE 330 UK: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 343 TABLE 331 UK: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 343 TABLE 332 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 343 TABLE 333 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 344 TABLE 334 UK: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 344 TABLE 335 UK: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 345 TABLE 336 UK: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 345 TABLE 337 UK: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 346 TABLE 338 UK: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 346 TABLE 339 UK: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 347 TABLE 340 UK: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 347 TABLE 341 UK: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 348 TABLE 342 UK: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 348 TABLE 343 UK: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 349 TABLE 344 UK: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 349 TABLE 345 UK: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 350 TABLE 346 UK: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 350 TABLE 347 UK: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 350 TABLE 348 UK: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 351 TABLE 349 UK: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 351 TABLE 350 UK: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 352 TABLE 351 UK: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 352 TABLE 352 UK: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 353 TABLE 353 UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 353 TABLE 354 UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 354 TABLE 355 FRANCE: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 355 TABLE 356 FRANCE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 355 TABLE 357 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 356 TABLE 358 FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 356 TABLE 359 FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 357 TABLE 360 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 357 TABLE 361 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 358 TABLE 362 FRANCE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 358 TABLE 363 FRANCE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 359 TABLE 364 FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 359 TABLE 365 FRANCE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 360 TABLE 366 FRANCE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 360 TABLE 367 FRANCE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 361 TABLE 368 FRANCE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 361 TABLE 369 FRANCE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 362 TABLE 370 FRANCE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 362 TABLE 371 FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 363 TABLE 372 FRANCE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 363 TABLE 373 FRANCE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 364 TABLE 374 FRANCE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 364 TABLE 375 FRANCE: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 364 TABLE 376 FRANCE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 365 TABLE 377 FRANCE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 365 TABLE 378 FRANCE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 366 TABLE 379 FRANCE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 366 TABLE 380 FRANCE: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 367 TABLE 381 FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 367 TABLE 382 FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 368 TABLE 383 ITALY: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 369 TABLE 384 ITALY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 369 TABLE 385 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 370 TABLE 386 ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 370 TABLE 387 ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 371 TABLE 388 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 371 TABLE 389 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 372 TABLE 390 ITALY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 372 TABLE 391 ITALY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 373 TABLE 392 ITALY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 373 TABLE 393 ITALY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 374 TABLE 394 ITALY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 374 TABLE 395 ITALY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 375 TABLE 396 ITALY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 375 TABLE 397 ITALY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 376 TABLE 398 ITALY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 376 TABLE 399 ITALY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 377 TABLE 400 ITALY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 377 TABLE 401 ITALY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 378 TABLE 402 ITALY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 378 TABLE 403 ITALY: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 378 TABLE 404 ITALY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 379 TABLE 405 ITALY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 379 TABLE 406 ITALY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 407 ITALY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 408 ITALY: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 381 TABLE 409 ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 381 TABLE 410 ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 382 TABLE 411 SPAIN: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 383 TABLE 412 SPAIN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 383 TABLE 413 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 384 TABLE 414 SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 384 TABLE 415 SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 385 TABLE 416 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 385 TABLE 417 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 386 TABLE 418 SPAIN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 386 TABLE 419 SPAIN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 387 TABLE 420 SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 387 TABLE 421 SPAIN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 388 TABLE 422 SPAIN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 388 TABLE 423 SPAIN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 389 TABLE 424 SPAIN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 389 TABLE 425 SPAIN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 390 TABLE 426 SPAIN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 390 TABLE 427 SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 391 TABLE 428 SPAIN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 391 TABLE 429 SPAIN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 392 TABLE 430 SPAIN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 392 TABLE 431 SPAIN: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 392 TABLE 432 SPAIN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 393 TABLE 433 SPAIN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 393 TABLE 434 SPAIN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 394 TABLE 435 SPAIN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 394 TABLE 436 SPAIN: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 394 TABLE 437 SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 395 TABLE 438 SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 395 TABLE 439 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 396 TABLE 440 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 397 TABLE 441 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 397 TABLE 442 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 398 TABLE 443 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 398 TABLE 444 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 399 TABLE 445 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 399 TABLE 446 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 400 TABLE 447 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 400 TABLE 448 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 401 TABLE 449 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 401 TABLE 450 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 402 TABLE 451 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 402 TABLE 452 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 403 TABLE 453 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 403 TABLE 454 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 404 TABLE 455 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 404 TABLE 456 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 405 TABLE 457 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 405 TABLE 458 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 406 TABLE 459 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 406 TABLE 460 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 407 TABLE 461 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 407 TABLE 462 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 408 TABLE 463 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 408 TABLE 464 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 409 TABLE 465 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 409 TABLE 466 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 410 TABLE 467 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 412 TABLE 468 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 412 TABLE 469 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 413 TABLE 470 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 413 TABLE 471 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 414 TABLE 472 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 414 TABLE 473 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 414 TABLE 474 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 415 TABLE 475 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 415 TABLE 476 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 416 TABLE 477 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 416 TABLE 478 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 417 TABLE 479 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 417 TABLE 480 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 418 TABLE 481 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 418 TABLE 482 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 419 TABLE 483 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 419 TABLE 484 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 420 TABLE 485 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 420 TABLE 486 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 421 TABLE 487 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 421 TABLE 488 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 421 TABLE 489 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 422 TABLE 490 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 422 TABLE 491 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 423 TABLE 492 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 423 TABLE 493 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 423 TABLE 494 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 424 TABLE 495 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 424 TABLE 496 CHINA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 425 TABLE 497 CHINA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 426 TABLE 498 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 426 TABLE 499 CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 427 TABLE 500 CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 427 TABLE 501 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 427 TABLE 502 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 428 TABLE 503 CHINA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 428 TABLE 504 CHINA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 429 TABLE 505 CHINA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 429 TABLE 506 CHINA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 430 TABLE 507 CHINA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 430 TABLE 508 CHINA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 509 CHINA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 510 CHINA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 432 TABLE 511 CHINA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 432 TABLE 512 CHINA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 433 TABLE 513 CHINA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 433 TABLE 514 CHINA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 434 TABLE 515 CHINA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 434 TABLE 516 CHINA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 434 TABLE 517 CHINA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 435 TABLE 518 CHINA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 435 TABLE 519 CHINA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 436 TABLE 520 CHINA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 436 TABLE 521 CHINA: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 437 TABLE 522 CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 437 TABLE 523 CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 437 TABLE 524 JAPAN: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 438 TABLE 525 JAPAN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 439 TABLE 526 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 439 TABLE 527 JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 440 TABLE 528 JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 440 TABLE 529 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 440 TABLE 530 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 441 TABLE 531 JAPAN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 441 TABLE 532 JAPAN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 442 TABLE 533 JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 442 TABLE 534 JAPAN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 443 TABLE 535 JAPAN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 443 TABLE 536 JAPAN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 444 TABLE 537 JAPAN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 444 TABLE 538 JAPAN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 445 TABLE 539 JAPAN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 445 TABLE 540 JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 446 TABLE 541 JAPAN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 446 TABLE 542 JAPAN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 447 TABLE 543 JAPAN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 447 TABLE 544 JAPAN: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 447 TABLE 545 JAPAN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 448 TABLE 546 JAPAN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 448 TABLE 547 JAPAN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 449 TABLE 548 JAPAN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 449 TABLE 549 JAPAN: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 449 TABLE 550 JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 450 TABLE 551 JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 450 TABLE 552 INDIA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 452 TABLE 553 INDIA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 452 TABLE 554 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 453 TABLE 555 INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 453 TABLE 556 INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 454 TABLE 557 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 454 TABLE 558 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 455 TABLE 559 INDIA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 455 TABLE 560 INDIA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 456 TABLE 561 INDIA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 456 TABLE 562 INDIA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 457 TABLE 563 INDIA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 457 TABLE 564 INDIA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 458 TABLE 565 INDIA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 458 TABLE 566 INDIA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 459 TABLE 567 INDIA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 459 TABLE 568 INDIA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 460 TABLE 569 INDIA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 460 TABLE 570 INDIA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 461 TABLE 571 INDIA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 461 TABLE 572 INDIA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 461 TABLE 573 INDIA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 462 TABLE 574 INDIA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 462 TABLE 575 INDIA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 463 TABLE 576 INDIA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 463 TABLE 577 INDIA: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 463 TABLE 578 INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 464 TABLE 579 INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 464 TABLE 580 AUSTRALIA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 465 TABLE 581 AUSTRALIA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 466 TABLE 582 AUSTRALIA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 583 AUSTRALIA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 467 TABLE 584 AUSTRALIA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 467 TABLE 585 AUSTRALIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 467 TABLE 586 AUSTRALIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 468 TABLE 587 AUSTRALIA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 468 TABLE 588 AUSTRALIA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 469 TABLE 589 AUSTRALIA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 469 TABLE 590 AUSTRALIA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 470 TABLE 591 AUSTRALIA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 470 TABLE 592 AUSTRALIA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 471 TABLE 593 AUSTRALIA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 471 TABLE 594 AUSTRALIA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 472 TABLE 595 AUSTRALIA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 472 TABLE 596 AUSTRALIA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 473 TABLE 597 AUSTRALIA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 473 TABLE 598 AUSTRALIA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 474 TABLE 599 AUSTRALIA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 474 TABLE 600 AUSTRALIA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 474 TABLE 601 AUSTRALIA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 475 TABLE 602 AUSTRALIA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 475 TABLE 603 AUSTRALIA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 476 TABLE 604 AUSTRALIA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 476 TABLE 605 AUSTRALIA: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 476 TABLE 606 AUSTRALIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 477 TABLE 607 AUSTRALIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 477 TABLE 608 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 478 TABLE 609 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 479 TABLE 610 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 479 TABLE 611 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 480 TABLE 612 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 480 TABLE 613 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 480 TABLE 614 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 481 TABLE 615 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 481 TABLE 616 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 482 TABLE 617 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 482 TABLE 618 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 483 TABLE 619 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 483 TABLE 620 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 621 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 622 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 485 TABLE 623 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 485 TABLE 624 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 486 TABLE 625 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 486 TABLE 626 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 487 TABLE 627 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 487 TABLE 628 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 487 TABLE 629 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 488 TABLE 630 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 488 TABLE 631 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 489 TABLE 632 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 489 TABLE 633 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 489 TABLE 634 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 490 TABLE 635 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 490 TABLE 636 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 491 TABLE 637 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 492 TABLE 638 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 492 TABLE 639 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 493 TABLE 640 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 493 TABLE 641 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 493 TABLE 642 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 494 TABLE 643 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 494 TABLE 644 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 495 TABLE 645 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 495 TABLE 646 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 496 TABLE 647 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 496 TABLE 648 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 497 TABLE 649 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 497 TABLE 650 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 498 TABLE 651 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 498 TABLE 652 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 499 TABLE 653 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 499 TABLE 654 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 500 TABLE 655 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 500 TABLE 656 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 500 TABLE 657 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 501 TABLE 658 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 501 TABLE 659 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 660 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 661 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 503 TABLE 662 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 503 TABLE 663 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 503 TABLE 664 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 505 TABLE 665 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 505 TABLE 666 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 506 TABLE 667 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 506 TABLE 668 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 507 TABLE 669 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 507 TABLE 670 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 507 TABLE 671 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 508 TABLE 672 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 508 TABLE 673 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 674 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 675 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 510 TABLE 676 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 510 TABLE 677 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 511 TABLE 678 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 511 TABLE 679 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 512 TABLE 680 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 512 TABLE 681 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 513 TABLE 682 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 513 TABLE 683 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 514 TABLE 684 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 514 TABLE 685 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 514 TABLE 686 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 515 TABLE 687 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 515 TABLE 688 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 689 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 690 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 516 TABLE 691 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 692 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 693 BRAZIL: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 518 TABLE 694 BRAZIL: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 519 TABLE 695 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 519 TABLE 696 BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 520 TABLE 697 BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 520 TABLE 698 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 520 TABLE 699 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 521 TABLE 700 BRAZIL: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 521 TABLE 701 BRAZIL: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 522 TABLE 702 BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 522 TABLE 703 BRAZIL: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 523 TABLE 704 BRAZIL: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 523 TABLE 705 BRAZIL: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 524 TABLE 706 BRAZIL: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 524 TABLE 707 BRAZIL: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 525 TABLE 708 BRAZIL: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 525 TABLE 709 BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 526 TABLE 710 BRAZIL: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 526 TABLE 711 BRAZIL: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 527 TABLE 712 BRAZIL: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 527 TABLE 713 BRAZIL: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 527 TABLE 714 BRAZIL: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 528 TABLE 715 BRAZIL: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 528 TABLE 716 BRAZIL: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 529 TABLE 717 BRAZIL: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 529 TABLE 718 BRAZIL: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 529 TABLE 719 BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 530 TABLE 720 BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 530 TABLE 721 MEXICO: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 531 TABLE 722 MEXICO: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 532 TABLE 723 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 532 TABLE 724 MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 533 TABLE 725 MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 533 TABLE 726 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 533 TABLE 727 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 534 TABLE 728 MEXICO: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 534 TABLE 729 MEXICO: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 535 TABLE 730 MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 535 TABLE 731 MEXICO: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 536 TABLE 732 MEXICO: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 536 TABLE 733 MEXICO: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 537 TABLE 734 MEXICO: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 537 TABLE 735 MEXICO: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 538 TABLE 736 MEXICO: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 538 TABLE 737 MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 539 TABLE 738 MEXICO: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 539 TABLE 739 MEXICO: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 540 TABLE 740 MEXICO: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 540 TABLE 741 MEXICO: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 540 TABLE 742 MEXICO: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 541 TABLE 743 MEXICO: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 541 TABLE 744 MEXICO: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 542 TABLE 745 MEXICO: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 542 TABLE 746 MEXICO: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 542 TABLE 747 MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 543 TABLE 748 MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 543 TABLE 749 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 544 TABLE 750 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 545 TABLE 751 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 545 TABLE 752 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 546 TABLE 753 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 546 TABLE 754 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 546 TABLE 755 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 547 TABLE 756 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 547 TABLE 757 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 548 TABLE 758 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 548 TABLE 759 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 549 TABLE 760 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 549 TABLE 761 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 550 TABLE 762 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 550 TABLE 763 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 551 TABLE 764 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 551 TABLE 765 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 552 TABLE 766 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 552 TABLE 767 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 553 TABLE 768 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 553 TABLE 769 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 553 TABLE 770 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 554 TABLE 771 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 554 TABLE 772 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 555 TABLE 773 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 555 TABLE 774 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 555 TABLE 775 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 556 TABLE 776 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 556 TABLE 777 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 557 TABLE 778 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 558 TABLE 779 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 558 TABLE 780 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 559 TABLE 781 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 559 TABLE 782 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 560 TABLE 783 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 560 TABLE 784 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 561 TABLE 785 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 561 TABLE 786 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 562 TABLE 787 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 562 TABLE 788 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 563 TABLE 789 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 563 TABLE 790 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 564 TABLE 791 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 564 TABLE 792 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 565 TABLE 793 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 565 TABLE 794 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 566 TABLE 795 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 566 TABLE 796 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 567 TABLE 797 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 567 TABLE 798 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 567 TABLE 799 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 568 TABLE 800 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 568 TABLE 801 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 569 TABLE 802 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 569 TABLE 803 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 569 TABLE 804 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 570 TABLE 805 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 570 TABLE 806 GCC: AI IN HEALTHCARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 571 TABLE 807 GCC: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 571 TABLE 808 GCC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 572 TABLE 809 GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 572 TABLE 810 GCC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 573 TABLE 811 GCC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 573 TABLE 812 GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 573 TABLE 813 GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 574 TABLE 814 GCC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 574 TABLE 815 GCC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 575 TABLE 816 GCC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 575 TABLE 817 GCC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 576 TABLE 818 GCC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 576 TABLE 819 GCC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 577 TABLE 820 GCC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 577 TABLE 821 GCC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 578 TABLE 822 GCC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 578 TABLE 823 GCC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 579 TABLE 824 GCC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 579 TABLE 825 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 580 TABLE 826 GCC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 580 TABLE 827 GCC: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 580 TABLE 828 GCC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 581 TABLE 829 GCC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 581 TABLE 830 GCC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 582 TABLE 831 GCC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 582 TABLE 832 GCC: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 582 TABLE 833 GCC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 583 TABLE 834 GCC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 583 TABLE 835 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 584 TABLE 836 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 584 TABLE 837 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 585 TABLE 838 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 585 TABLE 839 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 586 TABLE 840 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 586 TABLE 841 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 587 TABLE 842 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 587 TABLE 843 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 588 TABLE 844 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 588 TABLE 845 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 589 TABLE 846 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 589 TABLE 847 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 590 TABLE 848 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 590 TABLE 849 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 591 TABLE 850 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 591 TABLE 851 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 592 TABLE 852 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 592 TABLE 853 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 593 TABLE 854 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 593 TABLE 855 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 593 TABLE 856 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 594 TABLE 857 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 594 TABLE 858 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 595 TABLE 859 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 595 TABLE 860 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 595 TABLE 861 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 596 TABLE 862 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 596 TABLE 863 UAE: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 597 TABLE 864 UAE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 598 TABLE 865 UAE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 598 TABLE 866 UAE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 599 TABLE 867 UAE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 599 TABLE 868 UAE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 599 TABLE 869 UAE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 600 TABLE 870 UAE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 600 TABLE 871 UAE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 601 TABLE 872 UAE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 601 TABLE 873 UAE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 602 TABLE 874 UAE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 602 TABLE 875 UAE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 603 TABLE 876 UAE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 603 TABLE 877 UAE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 604 TABLE 878 UAE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 604 TABLE 879 UAE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 605 TABLE 880 UAE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 605 TABLE 881 UAE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 606 TABLE 882 UAE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 606 TABLE 883 UAE: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 606 TABLE 884 UAE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 607 TABLE 885 UAE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 607 TABLE 886 UAE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 608 TABLE 887 UAE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 608 TABLE 888 UAE: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 608 TABLE 889 UAE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 609 TABLE 890 UAE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 609 TABLE 891 REST OF GCC: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 610 TABLE 892 REST OF GCC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 610 TABLE 893 REST OF GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 611 TABLE 894 REST OF GCC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 611 TABLE 895 REST OF GCC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 612 TABLE 896 REST OF GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 612 TABLE 897 REST OF GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 613 TABLE 898 REST OF GCC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 613 TABLE 899 REST OF GCC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 614 TABLE 900 REST OF GCC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 614 TABLE 901 REST OF GCC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 615 TABLE 902 REST OF GCC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 615 TABLE 903 REST OF GCC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 616 TABLE 904 REST OF GCC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 616 TABLE 905 REST OF GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 617 TABLE 906 REST OF GCC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 617 TABLE 907 REST OF GCC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 618 TABLE 908 REST OF GCC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 618 TABLE 909 REST OF GCC: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 619 TABLE 910 REST OF GCC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 619 TABLE 911 REST OF GCC: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 619 TABLE 912 REST OF GCC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 620 TABLE 913 REST OF GCC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 620 TABLE 914 REST OF GCC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 621 TABLE 915 REST OF GCC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 621 TABLE 916 REST OF GCC: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 621 TABLE 917 REST OF GCC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 622 TABLE 918 REST OF GCC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 622 TABLE 919 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 623 TABLE 920 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 624 TABLE 921 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 624 TABLE 922 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 625 TABLE 923 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 625 TABLE 924 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 625 TABLE 925 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 626 TABLE 926 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 626 TABLE 927 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 627 TABLE 928 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 627 TABLE 929 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 628 TABLE 930 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 628 TABLE 931 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 629 TABLE 932 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 629 TABLE 933 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 630 TABLE 934 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 630 TABLE 935 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 631 TABLE 936 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 631 TABLE 937 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 632 TABLE 938 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 632 TABLE 939 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 632 TABLE 940 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 633 TABLE 941 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 633 TABLE 942 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 634 TABLE 943 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 634 TABLE 944 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 634 TABLE 945 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 635 TABLE 946 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 635 TABLE 947 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 636 TABLE 948 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 636 TABLE 949 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 637 TABLE 950 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 637 TABLE 951 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 638 TABLE 952 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 638 TABLE 953 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 639 TABLE 954 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 639 TABLE 955 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 640 TABLE 956 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 640 TABLE 957 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 641 TABLE 958 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 641 TABLE 959 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 642 TABLE 960 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 642 TABLE 961 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 643 TABLE 962 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 643 TABLE 963 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 644 TABLE 964 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 644 TABLE 965 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 645 TABLE 966 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 645 TABLE 967 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 645 TABLE 968 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 646 TABLE 969 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 646 TABLE 970 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 647 TABLE 971 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 647 TABLE 972 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 647 TABLE 973 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 648 TABLE 974 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 648 TABLE 975 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET, JANUARY 2023–JUNE 2026 649 TABLE 976 AI IN HEALTHCARE MARKET SHARE ANALYSIS, 2025 654 TABLE 977 AI IN HEALTHCARE MARKET: REGION FOOTPRINT 658 TABLE 978 AI IN HEALTHCARE MARKET: APPLICATION FOOTPRINT 659 TABLE 979 AI IN HEALTHCARE MARKET: TOOL FOOTPRINT 660 TABLE 980 AI IN HEALTHCARE MARKET: FUNCTION FOOTPRINT, 2025 661 TABLE 981 AI IN HEALTHCARE MARKET: OFFERING FOOTPRINT 662 TABLE 982 AI IN HEALTHCARE MARKET: DEPLOYMENT FOOTPRINT 663 TABLE 983 AI IN HEALTHCARE MARKET: END USER FOOTPRINT, 2025 664 TABLE 984 AI IN HEALTHCARE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS, 2025 667 TABLE 985 AI IN HEALTHCARE MARKET: APPLICATION AND REGIONAL FOOTPRINT (STARTUPS/SMES), 2025 667 TABLE 986 AI IN HEALTHCARE MARKET: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS, JANUARY 2023–JUNE 2026 669 TABLE 987 AI IN HEALTHCARE MARKET: DEALS, JANUARY 2023–JUNE 2026 671 TABLE 988 AI IN HEALTHCARE MARKET: OTHER DEVELOPMENTS, JANUARY 2023–JUNE 2026 672 TABLE 989 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 673 TABLE 990 KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES OFFERED 674 TABLE 991 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 676 TABLE 992 KONINKLIJKE PHILIPS N.V.: DEALS 678 TABLE 993 KONINKLIJKE PHILIPS N.V.: EXPANSIONS 680 TABLE 994 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS 681 TABLE 995 MICROSOFT CORPORATION: COMPANY OVERVIEW 682 TABLE 996 MICROSOFT CORPORATION: PRODUCTS & SERVICES OFFERED 683 TABLE 997 MICROSOFT CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 685 TABLE 998 MICROSOFT CORPORATION: DEALS 686 TABLE 999 NVIDIA CORPORATION: COMPANY OVERVIEW 689 TABLE 1000 NVIDIA CORPORATION: PRODUCTS & SERVICES OFFERED 690 TABLE 1001 NVIDIA CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 691 TABLE 1002 NVIDIA CORPORATION: DEALS 692 TABLE 1003 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 695 TABLE 1004 SIEMENS HEALTHINEERS AG: PRODUCTS & SERVICES OFFERED 696 TABLE 1005 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 698 TABLE 1006 SIEMENS HEALTHINEERS AG: DEALS 699 TABLE 1007 GE HEALTHCARE: COMPANY OVERVIEW 702 TABLE 1008 GE HEALTHCARE: PRODUCTS & SERVICES OFFERED 703 TABLE 1009 GE HEALTHCARE: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 705 TABLE 1010 GE HEALTHCARE: DEALS 705 TABLE 1011 GE HEALTHCARE: OTHER DEVELOPMENTS 707 TABLE 1012 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 708 TABLE 1013 EPIC SYSTEMS CORPORATION: PRODUCTS & SERVICES OFFERED 708 TABLE 1014 EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 709 TABLE 1015 EPIC SYSTEMS CORPORATION: DEALS 709 TABLE 1016 ORACLE: COMPANY OVERVIEW 710 TABLE 1017 ORACLE: PRODUCTS & SERVICES OFFERED 711 TABLE 1018 ORACLE: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 712 TABLE 1019 ORACLE CORPORATION: DEALS 713 TABLE 1020 ORACLE: EXPANSIONS 714 TABLE 1021 VERADIGM LLC: COMPANY OVERVIEW 715 TABLE 1022 VERADIGM LLC: PRODUCTS & SERVICES OFFERED 715 TABLE 1023 VERADIGM LLC: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 716 TABLE 1024 VERADIGM LLC: DEALS 717 TABLE 1025 AMAZON WEB SERVICES, INC.: COMPANY OVERVIEW 718 TABLE 1026 AMAZON WEB SERVICES, INC.: PRODUCTS & SERVICES OFFERED 719 TABLE 1027 AMAZON WEB SERVICES, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 720 TABLE 1028 AMAZON WEB SERVICES, INC.: DEALS 721 TABLE 1029 AMAZON WEB SERVICES, INC.: EXPANSIONS 722 TABLE 1030 MERATIVE: COMPANY OVERVIEW 723 TABLE 1031 MERATIVE: PRODUCTS & SERVICES OFFERED 723 TABLE 1032 MERATIVE: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 724 TABLE 1033 MERATIVE: DEALS 724 TABLE 1034 IBM: COMPANY OVERVIEW 725 TABLE 1035 IBM: PRODUCTS & SERVICES OFFERED 726 TABLE 1036 IBM: DEALS 727 TABLE 1037 MEDTRONIC: COMPANY OVERVIEW 728 TABLE 1038 MEDTRONIC: PRODUCTS & SERVICES OFFERED 729 TABLE 1039 MEDTRONIC: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 730 TABLE 1040 MEDTRONIC: DEALS 731 TABLE 1041 GOOGLE: COMPANY OVERVIEW 732 TABLE 1042 GOOGLE: PRODUCTS & SERVICES OFFERED 733 TABLE 1043 GOOGLE: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 735 TABLE 1044 GOOGLE: DEALS 736 TABLE 1045 GOOGLE: OTHER DEVELOPMENTS 738 TABLE 1046 SOPHIA GENETICS: COMPANY OVERVIEW 739 TABLE 1047 SOPHIA GENETICS: PRODUCTS & SERVICES OFFERED 740 TABLE 1048 SOPHIA GENETICS: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 740 TABLE 1049 SOPHIA GENETICS: DEALS 741 TABLE 1050 SOPHIA GENETICS: OTHER DEVELOPMENTS 742 TABLE 1051 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW 743 TABLE 1052 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS & SERVICES OFFERED 744 TABLE 1053 JOHNSON & JOHNSON SERVICES, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 745 TABLE 1054 JOHNSON & JOHNSON SERVICES, INC.: DEALS 745 TABLE 1055 TEMPUS AI, INC.: COMPANY OVERVIEW 746 TABLE 1056 TEMPUS AI, INC.: PRODUCTS & SERVICES OFFERED 747 TABLE 1057 TEMPUS AI, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 748 TABLE 1058 TEMPUS AI, INC.: DEALS 749 TABLE 1059 CONCERTAI: COMPANY OVERVIEW 751 TABLE 1060 CONCERTAI: PRODUCTS & SERVICES OFFERED 751 TABLE 1061 CONCERTAI: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 752 TABLE 1062 CONCERTAI: DEALS 753 TABLE 1063 SOLVENTUM CORPORATION: COMPANY OVERVIEW 755 TABLE 1064 SOLVENTUM CORPORATION: PRODUCTS & SERVICES OFFERED 756 TABLE 1065 SOLVENTUM CORPORATION: DEALS 757 TABLE 1066 SOLVENTUM CORPORATION: OTHER DEVELOPMENTS 758 TABLE 1067 COGNIZANT: COMPANY OVERVIEW 759 TABLE 1068 COGNIZANT: PRODUCTS & SERVICES OFFERED 760 TABLE 1069 COGNIZANT: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 761 TABLE 1070 COGNIZANT: DEALS 762 TABLE 1071 VIZ.AI, INC.: COMPANY OVERVIEW 763 TABLE 1072 VIZ.AI, INC.: PRODUCTS & SERVICES OFFERED 763 TABLE 1073 VIZ.AI, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 764 TABLE 1074 VIZ.AI, INC.: DEALS 764 TABLE 1075 VIZ.AI, INC.: OTHER DEVELOPMENTS 766 TABLE 1076 RIVERAIN TECHNOLOGIES: COMPANY OVERVIEW 767 TABLE 1077 RIVERAIN TECHNOLOGIES: PRODUCTS & SERVICES OFFERED 767 TABLE 1078 RIVERAIN TECHNOLOGIES: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 768 TABLE 1079 RIVERAIN TECHNOLOGIES: DEALS 768 TABLE 1080 STUDY ASSUMPTIONS 785 TABLE 1081 AI IN HEALTHCARE MARKET: RISK ASSESSMENT 786 FIGURE 1 MARKETS COVERED AND REGIONAL SCOPE 67 FIGURE 2 DURATION COVERED IN REPORT 71 FIGURE 3 MARKET SCENARIO 74 FIGURE 4 GLOBAL AI IN HEALTHCARE MARKET, 2024–2031 74 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2023–2026 75 FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF AI IN HEALTHCARE MARKET 76 FIGURE 7 HIGH-GROWTH SEGMENTS IN AI IN HEALTHCARE MARKET, 2026–2031 77 FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN AI IN HEALTHCARE MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 78 FIGURE 9 RAPID PROLIFERATION OF AI IN HOSPITALS TO DRIVE GROWTH OF AI IN HEALTHCARE MARKET 79 FIGURE 10 CLINICAL APPLICATIONS AND US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2025 80 FIGURE 11 INDIA TO REGISTER HIGHEST GROWTH RATE IN GLOBAL AI IN HEALTHCARE MARKET DURING FORECAST PERIOD 80 FIGURE 12 AI IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 81 FIGURE 13 AI IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 95 FIGURE 14 AI IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS 98 FIGURE 15 AI IN HEALTHCARE ECOSYSTEM ANALYSIS 99 FIGURE 16 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESSES 103 FIGURE 18 JURISDICTION AND TOP APPLICANT ANALYSIS FOR AI IN HEALTHCARE MARKET 114 FIGURE 19 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR AI IN HEALTHCARE MARKET (JANUARY 2015 TO DECEMBER 2025) 115 FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 125 FIGURE 21 KEY BUYING CRITERIA FOR TOP 3 END USERS 126 FIGURE 22 NORTH AMERICA: AI IN HEALTHCARE MARKET SNAPSHOT 269 FIGURE 23 ASIA PACIFIC: AI IN HEALTHCARE MARKET SNAPSHOT 411 FIGURE 24 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2021–2025 652 FIGURE 25 MARKET SHARE ANALYSIS OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2025 653 FIGURE 26 AI IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 656 FIGURE 27 AI IN HEALTHCARE MARKET: COMPANY FOOTPRINT, 2025 657 FIGURE 28 AI IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 666 FIGURE 29 EV/EBITDA OF KEY VENDORS, 2026 668 FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2026 668 FIGURE 31 AI IN HEALTHCARE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 669 FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 674 FIGURE 33 MICROSOFT CORPORATION: COMPANY SNAPSHOT 683 FIGURE 34 NVIDIA CORPORATION: COMPANY SNAPSHOT 690 FIGURE 35 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 696 FIGURE 36 GE HEALTHCARE: COMPANY SNAPSHOT 703 FIGURE 37 ORACLE: COMPANY SNAPSHOT 711 FIGURE 38 AMAZON WEB SERVICES, INC.: COMPANY SNAPSHOT 719 FIGURE 39 IBM: COMPANY SNAPSHOT 726 FIGURE 40 MEDTRONIC: COMPANY SNAPSHOT 729 FIGURE 41 GOOGLE: COMPANY SNAPSHOT 733 FIGURE 42 SOPHIA GENETICS: COMPANY SNAPSHOT 739 FIGURE 43 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT 744 FIGURE 44 TEMPUS: COMPANY SNAPSHOT 747 FIGURE 45 SOLVENTUM CORPORATION: COMPANY SNAPSHOT 756 FIGURE 46 COGNIZANT: COMPANY SNAPSHOT 760 FIGURE 47 RESEARCH DESIGN 774 FIGURE 48 KEY DATA FROM SECONDARY SOURCES 776 FIGURE 49 PRIMARY SOURCES 777 FIGURE 50 KEY INSIGHTS FROM INDUSTRY EXPERTS 778 FIGURE 51 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE), BY COMPANY TYPE, DESIGNATION, AND REGION 779 FIGURE 52 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 780 FIGURE 53 BOTTOM-UP APPROACH: END USER SPENDING ON AI IN HEALTHCARE 781 FIGURE 54 AI IN HEALTHCARE MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 782 FIGURE 55 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 783 FIGURE 56 TOP-DOWN APPROACH 783 FIGURE 57 DATA TRIANGULATION METHODOLOGY 784

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們